SPONSORED BY A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click on the …
Category: Pharma Industry
SPONSORED BY A note from 340B Report CEO and Publisher Ted Slafsky: Please join us in welcoming Comprehensive Pharmacy Services to our growing group of 340B Report sponsors! And I hope you enjoy a new column from Trellis Rx’s Jerry …
SPONSORED BY A note from 340B Report CEO and Publisher Ted Slafsky: I encourage all of you to read Trellis Rx Chief Pharmacy Officer Jerry Buller’s great article in today’s issue about how 340B health systems can leverage specialty pharmacy …
If Mallinckrodt settles charges it evaded paying additional Medicaid rebate amounts on Acthar, it’s possible claims for 340B overcharges will be foreclosed. Source: Mallinckrodt DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges …
An electron microscope image of SARS-CoV2 (round gold objects), the virus that causes COVID-19. Source: NIAD-RML 340B Providers Could Face Drug Access Challenges Due to Coronavirus In theory, federal law and 340B program guidance should protect 340B entities from shouldering …
Drug manufacturers are doing a better job of providing the Health Resources and Services Administration (HRSA) with timely and accurate data needed to verify their 340B ceiling prices, the head of the federal 340B drug pricing program indicated today. Nonetheless, …
President Expected to Address Drug Prices in State of the Union Message In his State of the Union address tonight, President Trump is expected to announce an initiative to make insulin more affordable and to challenge Congress to pass legislation …
Breaking News
BREAKING: Drugmaker Xspire Owes 340B Refunds
Greetings Welcome to the pilot issue of 340B Report. We’re so glad to have you aboard! And now, let’s get to the news. BREAKING: Drugmaker Xspire Owes 340B Refunds Xspire Pharma, a privately held, specialty pharmaceutical company, owes refunds for …